Life ScienceCompany
Roche has acquired 45 companies, including 11 in the last 5 years. A total of 10 acquisitions came from private equity firms. It has also divested 2 assets.
Roche’s largest acquisition to date was in 2009, when it acquired Genentech for $46.8B. Roche has acquired in 10 different US states, and 9 countries. The Company’s most targeted sectors include life science (70%) and medical products (12%).
Join Mergr and gain access to Roche’s M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the life science sector.
M&A Summary
-
M&A Total Activity44
- M&A Buy Activity42
- M&A Sell Activity2
- Total Sectors Invested 8
- Total Countries Invested 9
- M&A Buy/Sell Connections 11
- M&A Advisors 5
Unlimited Searches
